439 related articles for article (PubMed ID: 18284209)
1. Functional characterization of the native NH2-terminal transactivation domain of the human androgen receptor: binding kinetics for interactions with TFIIF and SRC-1a.
Lavery DN; McEwan IJ
Biochemistry; 2008 Mar; 47(11):3352-9. PubMed ID: 18284209
[TBL] [Abstract][Full Text] [Related]
2. Induced alpha-helix structure in AF1 of the androgen receptor upon binding transcription factor TFIIF.
Kumar R; Betney R; Li J; Thompson EB; McEwan IJ
Biochemistry; 2004 Mar; 43(11):3008-13. PubMed ID: 15023052
[TBL] [Abstract][Full Text] [Related]
3. The human androgen receptor AF1 transactivation domain: interactions with transcription factor IIF and molten-globule-like structural characteristics.
Lavery DN; McEwan IJ
Biochem Soc Trans; 2006 Dec; 34(Pt 6):1054-7. PubMed ID: 17073749
[TBL] [Abstract][Full Text] [Related]
4. Interactions of the HIV-1 Tat and RAP74 proteins with the RNA polymerase II CTD phosphatase FCP1.
Abbott KL; Archambault J; Xiao H; Nguyen BD; Roeder RG; Greenblatt J; Omichinski JG; Legault P
Biochemistry; 2005 Mar; 44(8):2716-31. PubMed ID: 15723517
[TBL] [Abstract][Full Text] [Related]
5. NMR structure of a complex formed by the carboxyl-terminal domain of human RAP74 and a phosphorylated peptide from the central domain of the FCP1 phosphatase.
Yang A; Abbott KL; Desjardins A; Di Lello P; Omichinski JG; Legault P
Biochemistry; 2009 Mar; 48(9):1964-74. PubMed ID: 19215094
[TBL] [Abstract][Full Text] [Related]
6. Enhanced binding of RNAP II CTD phosphatase FCP1 to RAP74 following CK2 phosphorylation.
Abbott KL; Renfrow MB; Chalmers MJ; Nguyen BD; Marshall AG; Legault P; Omichinski JG
Biochemistry; 2005 Mar; 44(8):2732-45. PubMed ID: 15723518
[TBL] [Abstract][Full Text] [Related]
7. Solution structure of the carboxyl-terminal domain of RAP74 and NMR characterization of the FCP1-binding sites of RAP74 and human TFIIB.
Nguyen BD; Chen HT; Kobor MS; Greenblatt J; Legault P; Omichinski JG
Biochemistry; 2003 Feb; 42(6):1460-9. PubMed ID: 12578358
[TBL] [Abstract][Full Text] [Related]
8. In vitro regulation of reporter gene transcription by the androgen receptor AF1 domain.
Choudhry MA; McEwan IJ
Biochem Soc Trans; 2004 Dec; 32(Pt 6):1103-6. PubMed ID: 15506979
[TBL] [Abstract][Full Text] [Related]
9. The androgen receptor interacts with multiple regions of the large subunit of general transcription factor TFIIF.
Reid J; Murray I; Watt K; Betney R; McEwan IJ
J Biol Chem; 2002 Oct; 277(43):41247-53. PubMed ID: 12181312
[TBL] [Abstract][Full Text] [Related]
10. Induced alpha-helix structure in the aryl hydrocarbon receptor transactivation domain modulates protein-protein interactions.
Watt K; Jess TJ; Kelly SM; Price NC; McEwan IJ
Biochemistry; 2005 Jan; 44(2):734-43. PubMed ID: 15641800
[TBL] [Abstract][Full Text] [Related]
11. Novel dimerization fold of RAP30/RAP74 in human TFIIF at 1.7 A resolution.
Gaiser F; Tan S; Richmond TJ
J Mol Biol; 2000 Oct; 302(5):1119-27. PubMed ID: 11183778
[TBL] [Abstract][Full Text] [Related]
12. Native-based simulations of the binding interaction between RAP74 and the disordered FCP1 peptide.
Kumar S; Showalter SA; Noid WG
J Phys Chem B; 2013 Mar; 117(11):3074-85. PubMed ID: 23387368
[TBL] [Abstract][Full Text] [Related]
13. Functional interaction of the c-Myc transactivation domain with the TATA binding protein: evidence for an induced fit model of transactivation domain folding.
McEwan IJ; Dahlman-Wright K; Ford J; Wright AP
Biochemistry; 1996 Jul; 35(29):9584-93. PubMed ID: 8755740
[TBL] [Abstract][Full Text] [Related]
14. GRIP1 mediates the interaction between the amino- and carboxyl-termini of the androgen receptor.
Shen HC; Buchanan G; Butler LM; Prescott J; Henderson M; Tilley WD; Coetzee GA
Biol Chem; 2005 Jan; 386(1):69-74. PubMed ID: 15843149
[TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of human RNA polymerase II subunit 5 (RPB5): the residues critical for interactions with TFIIF subunit RAP30 and hepatitis B virus X protein.
Le TT; Zhang S; Hayashi N; Yasukawa M; Delgermaa L; Murakami S
J Biochem; 2005 Sep; 138(3):215-24. PubMed ID: 16169872
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of androgen receptor associated coregulators in prostate cancer cells.
Sampson ER; Yeh SY; Chang HC; Tsai MY; Wang X; Ting HJ; Chang C
J Biol Regul Homeost Agents; 2001; 15(2):123-9. PubMed ID: 11501969
[TBL] [Abstract][Full Text] [Related]
17. The role of the general transcription factor IIF in androgen receptor-dependent transcription.
Choudhry MA; Ball A; McEwan IJ
Mol Endocrinol; 2006 Sep; 20(9):2052-61. PubMed ID: 16645039
[TBL] [Abstract][Full Text] [Related]
18. Agonist-antagonist induced coactivator and corepressor interplay on the human androgen receptor.
Dotzlaw H; Papaioannou M; Moehren U; Claessens F; Baniahmad A
Mol Cell Endocrinol; 2003 Dec; 213(1):79-85. PubMed ID: 15062576
[TBL] [Abstract][Full Text] [Related]
19. Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors.
Hodgson MC; Astapova I; Hollenberg AN; Balk SP
Cancer Res; 2007 Sep; 67(17):8388-95. PubMed ID: 17804755
[TBL] [Abstract][Full Text] [Related]
20. Interaction with general transcription factor IIF (TFIIF) is required for the suppression of activated transcription by RPB5-mediating protein (RMP).
Wei W; Gu JX; Zhu CQ; Sun FY; Dorjsuren D; Lin Y; Murakami S
Cell Res; 2003 Apr; 13(2):111-20. PubMed ID: 12737519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
